Pure Global
NCT06252181

Pain and Hemodynamics in Peripheral Arterial Disease: Response to Pulsed Electromagnetic Treatment

Pain and Hemodynamics in Peripheral Arterial Disease: Response to Pulsed Electromagnetic Treatment in Elderly
Ahram Canadian University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Peripheral Arterial Disease
Drug/Device/Intervention
electromagnetic pulsed therapy
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Ahram Canadian University
Location
Giza, Egypt
Timeline & enrollment
Phase
N/A
Start date
Dec 15, 2022
End date
Mar 10, 2024
Enrollment
40 participants
Primary outcome

ankle brachial index

Summary

patients with peripheral arterial disease are recommended to perform all exercise forms
 including elliptical type. electromagnetic treatment addition to exercise may increase
 benefits of this exercise

ICD-10 classifications
Peripheral vascular disease, unspecifiedOther peripheral vascular diseasesOther specified peripheral vascular diseasesPeripheral angiopathy in diseases classified elsewhereOther congenital malformations of peripheral vascular system
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06252181
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06252181 through Pure Global AI's free database. This phase not specified trial is sponsored by Ahram Canadian University and is currently Recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.